Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.6500
+0.0200 (3.17%)
At close: Nov 28, 2025
-4.41% (1Y)
| Market Cap | 33.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.82M |
| Shares Out | 51.84M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,000 |
| Average Volume | 30,297 |
| Open | 0.6500 |
| Previous Close | 0.6300 |
| Day's Range | 0.6500 - 0.6500 |
| 52-Week Range | 0.5100 - 0.8800 |
| Beta | 0.65 |
| RSI | 44.18 |
| Earnings Date | Nov 17, 2025 |